The largest shareholder of Chong Kun Dang Pharmaceutical transferred 1.31 million 8807 shares held by an executive.

An executive of Chong Kun Dang Pharmaceutical transferred 1,318,807 common shares held on October 2, 2026. An executive received 528,807 shares, another individual received 395,000 shares, and another individual received 395,000 shares respectively, and individual shareholdings changed accordingly. The largest shareholder group's overall stake is 40.15%.

1. 01

   An executive transferred all 1,318,807 shares held on October 2, 2026.

2. 02

   An executive received 528,807 shares and increased holdings from 204,813 shares to 733,620 shares.

3. 03

   An affiliate executive and another individual each received 395,000 shares.

4. 04

   Chongkundang Holdings and individual shareholders combined still own 40.15% of total shares.

An AI model translated the Korean summary of this filing into English; every number is carried over from the Korean original. Reference information, not investment advice.

Key figures

Shares transferred by executive

1,318,807 shares

Shares received by executive

528,807 shares

Shares received by affiliate executive

395,000 shares

Shares received by individual

395,000 shares

Transfer execution date

October 2, 2026

Disclosure filing date

October 8, 2026

Filing facts

Filing type

Largest Shareholder Holding Change

Report name

Report on Changes in Shares Held by the Largest Shareholder and Related Parties

Filed

Oct 8, 2026

Receipt number

20261008800916